Skip to main content
. 2020 Feb 21;86(6):1165–1175. doi: 10.1111/bcp.14229

Figure 2.

Figure 2

Serum infliximab concentrations and corresponding clinical response obtained in 52 patients of the control group managed with standard of care. TSIC: trough serum infliximab concentrations; supratherapeutic: TSIC <3 μg mL−1; therapeutic: TSIC 3–10 μg mL−1; supratherapeutic: TSIC >10 μg mL−1